Literature DB >> 22478837

The Biosimilars Act: Promoting or Discouraging the Development of Generic Biologics?: A tug-of-war between generic and innovator biologics seems to be where drug developers are headed.

Joanna T Brougher.   

Abstract

Congress may have unwittingly thrown roadblocks at makers of follow-on biologics.

Year:  2010        PMID： 22478837      PMCID： PMC3008392     

Source DB:  PubMed          Journal:  Biotechnol Healthc        ISSN： 1554-169X


  4 in total

1.  Doing more with less?: past and present challenges for the FDA.

Authors:  Jack McCain
Journal:  P T       Date:  2011-03

Review 2.  The Concept of Biosimilars: From Characterization to Evolution-A Narrative Review.

Authors:  Fadi Farhat; Alfredo Torres; Wungki Park; Gilberto de Lima Lopes; Raja Mudad; Chukwuemeka Ikpeazu; Simon Abi Aad
Journal:  Oncologist       Date:  2017-12-28

3.  Issues in assessing products for the treatment of hemophilia - the intersection between efficacy, economics, and ethics.

Authors:  Albert Farrugia; Declan Noone; Uwe Schlenkrich; Steffen Schlenkrich; Brian O'Mahony; Josephine Cassar
Journal:  J Blood Med       Date:  2015-06-15

Review 4.  Can biosimilars help achieve the goals of US health care reform?

Authors:  Ralph Boccia; Ira Jacobs; Robert Popovian; Gilberto de Lima Lopes
Journal:  Cancer Manag Res       Date:  2017-06-01       Impact factor: 3.989
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.